These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 17658067)

  • 21. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
    Schlom J; Weeks MO
    Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
    [No Abstract]   [Full Text] [Related]  

  • 22. Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.
    Ribas A; Camacho LH; Lopez-Berestein G; Pavlov D; Bulanhagui CA; Millham R; Comin-Anduix B; Reuben JM; Seja E; Parker CA; Sharma A; Glaspy JA; Gomez-Navarro J
    J Clin Oncol; 2005 Dec; 23(35):8968-77. PubMed ID: 16204013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alemtuzumab.
    Ravandi F; O'Brien S
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):39-51. PubMed ID: 15757437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Monoclonal antibodies as antineoplastic antibodies].
    Hashimoto Y
    Nihon Rinsho; 1983; 41(4):821-4. PubMed ID: 6887550
    [No Abstract]   [Full Text] [Related]  

  • 25. Adverse effects of the humanized antibodies used as cancer therapeutics.
    Klastersky J
    Curr Opin Oncol; 2006 Jul; 18(4):316-20. PubMed ID: 16721123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Half-match bone marrow transplants may raise odds for more recipients.
    Hede K
    J Natl Cancer Inst; 2011 May; 103(10):781-3. PubMed ID: 21551416
    [No Abstract]   [Full Text] [Related]  

  • 27. Glycoprotein A34, a novel target for antibody-based cancer immunotherapy.
    Scanlan MJ; Ritter G; Yin BW; Williams C; Cohen LS; Coplan KA; Fortunato SR; Frosina D; Lee SY; Murray AE; Chua R; Filonenko VV; Sato E; Old LJ; Jungbluth AA
    Cancer Immun; 2006 Jan; 6():2. PubMed ID: 16405301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody-directed therapies for hematological malignancies.
    Linenberger ML; Maloney DG; Bernstein ID
    Trends Mol Med; 2002 Feb; 8(2):69-76. PubMed ID: 11815272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance of the eye and vision in clinical trials of CP-675,206 for metastatic melanoma.
    Straatsma BR; Nusinowitz S; Young TA; Gordon LK; Chun MW; Rosen C; Seja E; Economou JS; Glaspy JA; Bozon V; Gomez-Navarro J; Ribas A
    Am J Ophthalmol; 2007 Jun; 143(6):958-969. PubMed ID: 17434437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor-directed targeting of liposomes.
    Park YS
    Biosci Rep; 2002 Apr; 22(2):267-81. PubMed ID: 12428904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia.
    Alinari L; Lapalombella R; Andritsos L; Baiocchi RA; Lin TS; Byrd JC
    Oncogene; 2007 May; 26(25):3644-53. PubMed ID: 17530018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioimmunotherapy of nude mice with intraperitoneally growing ovarian cancer xenograft utilizing 211At-labelled monoclonal antibody MOv18.
    Andersson H; Lindegren S; Back T; Jacobsson L; Leser G; Horvath G
    Anticancer Res; 2000; 20(1A):459-62. PubMed ID: 10769696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of hybridoma-exchange antibodies.
    Lloyd KO; Albino A; Houghton A
    Hybridoma; 1982; 1(4):461-3. PubMed ID: 6208140
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunotherapy and gene therapy of cancer using antibodies or their genes against tumor-associated antigens.
    Kuroki M; Shibaguchi H; Imakiire T; Uno K; Shirota K; Higuchi T; Shitama T; Yamada H; Hirose Y; Nagata A; Kuroki M
    Anticancer Res; 2003; 23(6a):4377-81. PubMed ID: 14666724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of monoclonal antibody immunoconjugates in cancer therapy.
    Pietersz GA; Krauer K; McKenzie IF
    Adv Exp Med Biol; 1994; 353():169-79. PubMed ID: 7985535
    [No Abstract]   [Full Text] [Related]  

  • 37. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
    Peggs KS; Quezada SA; Korman AJ; Allison JP
    Curr Opin Immunol; 2006 Apr; 18(2):206-13. PubMed ID: 16464564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibody may increase survival rate in patients with colorectal cancer.
    Oncology (Williston Park); 1998 Sep; 12(9):1350. PubMed ID: 9778682
    [No Abstract]   [Full Text] [Related]  

  • 39. [Passive immunotherapy with monoclonal antibodies].
    Bokemeyer C; Panse J
    Onkologie; 2005 Oct; 28 Suppl 4():9-13. PubMed ID: 16205099
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative study of the binding characteristics of monoclonal antimelanoma antibodies.
    Herlyn M; Steplewski Z; Atkinson BF; Ernst CS; Koprowski H
    Hybridoma; 1982; 1(4):403-11. PubMed ID: 6765323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.